Case Details
- Citation: [2025] SGHC 202
- Title: Vivaz Group Holdings Pte Ltd v TripleOne (Cambodia) Investment Pte Ltd (Lee Kok Heng Jeremiah, non-party)
- Court: High Court of the Republic of Singapore (General Division)
- Judges: Mohamed Faizal JC
- Date of decision: 14 October 2025
- Originating Application: HC/OA 1330 of 2024
- Summons: HC/SUM 2319 of 2025
- Related appeal: AD/CA 54 of 2025
- Plaintiff/Applicant: Vivaz Group Holdings Pte Ltd (“Vivaz”)
- Defendant/Respondent: TripleOne (Cambodia) Investment Pte Ltd (“Company”)
- Non-party: Lee Kok Heng Jeremiah (“Mr Lee”)
- Legal areas: Civil Procedure — Inherent powers; Companies — Statutory derivative action; Limitation of Actions — Breach of fiduciary duty
- Statutory framework referenced: Section 216A of the Companies Act 1967; Rules of Court 2021 (O 3 r 2(2), O 15 r 12(4)); comparative references to Australian and Hong Kong company legislation
- Judgment length: 34 pages, 10,783 words
Summary
Vivaz Group Holdings Pte Ltd v TripleOne (Cambodia) Investment Pte Ltd concerned a procedural problem that can arise in statutory derivative litigation: what should a claimant do when its application to commence a derivative action in the company’s name is dismissed at first instance, an appeal is pending, and the limitation period for the underlying corporate claims is likely to expire before the appeal is heard. The High Court addressed whether it had the power to grant a “protective writ” (by way of an originating claim in the company’s name) to preserve the company’s rights, and if so, whether such relief should be granted on the facts.
The court held that it did have the power to grant the protective writ, drawing on the statutory derivative action framework and the court’s procedural and inherent powers. Applying a balancing approach, the court granted permission for Vivaz to file the protective writ, but imposed a key condition: the protective writ was not to be served on the potential defendants of the derivative action pending the determination of the appeal. This ensured that the protective mechanism would preserve limitation without prematurely exposing the putative defendants to litigation steps while the appeal remained unresolved.
What Were the Facts of This Case?
Vivaz sought to bring a statutory derivative action under s 216A of the Companies Act 1967 (“Companies Act”) in the name and on behalf of the Company, TripleOne (Cambodia) Investment Pte Ltd. The intended derivative action primarily related to a board resolution dated 24 September 2019 (“Disposal of Shares Resolution”) which sanctioned the sale of all the Company’s shares in One Eleven Investment Pte Ltd (“OEI”) to TPC Properties Pte Ltd (“TPC”). Vivaz alleged that the resolution was orchestrated by two directors at the material time—Lee Kok Heng Jeremiah (“Mr Lee”) and Poh Boon Hua (“Mr Amos Poh”)—in breach of their duties to the Company.
In HC/OA 1330/2024 (“OA 1330”), Vivaz applied for the court’s permission to commence the derivative action. The High Court dismissed OA 1330 on 10 June 2025. Vivaz then appealed to the Appellate Division of the High Court in AD/CA 54/2025 (“CA 54”) on 7 July 2025. The court’s grounds for dismissing OA 1330 were subsequently published in Vivaz Group Holdings Pte Ltd v TripleOne (Cambodia) Investment Pte Ltd [2025] SGHC 176 (“Vivaz (Merits)”). In substance, the dismissal turned on Vivaz’s lack of good faith: the court found that Vivaz knew of the impugned transaction at the material time and therefore did not satisfy the good faith requirement for derivative relief.
While the appeal was pending, Vivaz faced a limitation risk. Vivaz contended that the Company’s claim against Mr Lee and Mr Amos Poh for breach of fiduciary duties arising from the Disposal of Shares Resolution would likely become time-barred on or about 24 September 2025. Because CA 54 had not yet been fixed for hearing and the parties had not yet been notified of the record of proceedings for OA 1330, Vivaz argued that the limitation period would expire before the appeal could be determined. If the limitation period expired, Vivaz’s appeal could become practically ineffective: even if the Appellate Division later allowed the derivative action, the underlying corporate claims might already be barred.
To address this, on 15 August 2025 Vivaz filed HC/SUM 2319/2025 (“SUM 2319”). The application sought permission to file a protective writ by way of an originating claim on behalf of the Company. Crucially, Vivaz proposed that the protective writ not be served on the “Potential Defendants” pending the determination of CA 54. The Potential Defendants included Mr Lee and Mr Amos Poh, TPC, and other recipients of the Company’s shares in OEI. Mr Lee, although a non-party to OA 1330, had objected to that earlier application; however, he did not object to SUM 2319.
What Were the Key Legal Issues?
The High Court identified two principal issues. First, it had to determine whether the court even possessed the power to grant SUM 2319—ie, whether the procedural law governing derivative actions and civil procedure permitted the court to authorise the filing of a protective writ in circumstances where the derivative action permission had been dismissed at first instance but was under appeal.
Second, assuming the power existed, the court had to decide whether SUM 2319 should be granted. This required the court to consider whether there was a “real need” for the protective writ, whether granting permission would strike the right balance between the interests of the parties, and whether it would avoid undue prejudice to the Potential Defendants. The court also had to consider whether Vivaz caused any inordinate delay and whether the earlier dismissal in CA 54 meant that SUM 2319 was likely to fail in any event (ie, whether the application was doomed because CA 54 was bound to fail).
How Did the Court Analyse the Issues?
1. Protective writs in derivative action applications: local guidance and comparative authority
The court noted that there was no local case authority directly considering an application like SUM 2319. It therefore examined existing Singapore guidance on protective measures in derivative contexts. In particular, the court found the obiter comments in Sinwa SS (HK) Co Ltd v Nordic International Ltd [2016] 4 SLR 320 (“Sinwa”) relevant. In Sinwa, the plaintiff sought leave to commence a common law derivative action where an arbitration clause required the dispute to be brought by arbitration in Singapore. The limitation expiry date for many claims fell between the filing of the derivative action application and the substantive hearing. The court held that filing the derivative action application did not stop the limitation period from running, and thus many claims were time-barred by the time the substantive hearing occurred. The judge in Sinwa rejected the argument that the plaintiff had no control over when the derivative application would be heard and suggested that the plaintiff could theoretically apply for permission to file the notice of arbitration in the company’s name pending the determination of the derivative action application. The High Court in Vivaz treated this as conceptually analogous to a “protective notice of arbitration”.
2. The court’s power to grant SUM 2319
Vivaz argued that the court had power to grant SUM 2319 under s 216A(5) of the Companies Act and/or O 3 r 2(2) of the Rules of Court 2021 (“ROC 2021”). Vivaz further submitted that the court could rely on inherent jurisdiction, and specifically on O 15 r 12(4) of the ROC 2021. It also argued that the doctrine of functus officio did not bar the application because SUM 2319 did not seek to revisit the substantive merits of the earlier dismissal in OA 1330.
The High Court accepted that the procedural question was novel and required careful framing. The court’s approach was to identify the purpose of s 216A and the court’s supervisory role in derivative actions. Section 216A is designed to permit shareholders to bring claims on behalf of a company in appropriate circumstances, but it also imposes gatekeeping requirements intended to prevent abuse. The protective writ mechanism sought in SUM 2319 was not directed at changing the substantive merits of the derivative action; rather, it was aimed at preserving the company’s limitation position while the appeal was pending. In that sense, the protective writ was treated as an interim procedural safeguard to prevent the appeal from being rendered nugatory by the operation of limitation law.
3. Whether there was a real need and whether the balance was appropriate
On the merits of whether SUM 2319 should be granted, the court focused on practical prejudice and necessity. The court accepted that if Vivaz succeeded in CA 54, it might otherwise obtain only a “paper judgment” because the fiduciary duty claims could be time-barred by 24 September 2025. The protective writ was therefore linked to the effectiveness of the appellate process. The court also considered whether the Potential Defendants would suffer prejudice. Vivaz’s proposal not to serve the protective writ on the Potential Defendants pending CA 54 was central to the balancing exercise. Without service, the Potential Defendants would not be compelled to take steps in response, incur litigation costs, or face immediate procedural burdens. The court further noted that the Appellate Division could, if necessary, set aside the permission or issue further directions, and that the protective writ would expire at the end of its validity period without extension unless ordered.
4. Delay and whether CA 54 was “bound to fail”
The court also addressed whether Vivaz had caused any inordinate delay. The record showed that SUM 2319 was filed in August 2025, after OA 1330 was dismissed in June 2025 and after Vivaz had appealed in July 2025. The court treated this timing as consistent with the limitation risk and the need to preserve rights before expiry. Finally, the court considered whether the earlier dismissal in OA 1330 meant that CA 54 was bound to fail, which would make SUM 2319 pointless. The court did not treat the existence of an arguable appeal as irrelevant; instead, it approached the question as one of whether the protective relief was proportionate and necessary pending the appeal, rather than as a mini-trial on the merits of CA 54.
What Was the Outcome?
The High Court granted Vivaz permission to file the protective writ by way of an originating claim on behalf of the Company. However, the court imposed a critical condition: the protective writ was not to be served on the Potential Defendants pending the determination of CA 54. This ensured that the protective mechanism would preserve the company’s limitation position while preventing premature litigation steps against those who were not yet subject to an operative derivative action permission.
In practical terms, the order allowed Vivaz to take a procedural step that could safeguard the Company’s claims from limitation expiry, while preserving the status quo for the Potential Defendants until the Appellate Division decided whether the derivative action permission should be granted.
Why Does This Case Matter?
This decision is significant because it addresses a gap in Singapore practice: the absence of clear local authority on protective writs (or analogous protective steps) in derivative action applications where limitation may expire before the appellate process concludes. The court’s reasoning provides a workable procedural pathway for claimants who face the risk that an appeal against derivative permission could become ineffective due to limitation law.
For practitioners, the case underscores that courts may be willing to grant interim procedural relief to prevent injustice, provided the relief is carefully tailored to avoid undue prejudice. The condition not to serve the protective writ pending the appeal reflects a judicial preference for proportionality: preserving rights without forcing immediate litigation burdens on putative defendants. The decision also reinforces the relevance of Sinwa’s obiter guidance and demonstrates how comparative reasoning from other common law jurisdictions can be used to fill doctrinal uncertainty.
Finally, the case highlights the importance of timing and good faith in derivative litigation. While the merits of Vivaz’s derivative permission were decided in the earlier case (Vivaz (Merits)), this later decision shows that even where derivative permission has been dismissed, procedural safeguards may still be available to ensure that appellate outcomes are not rendered illusory by limitation expiry.
Legislation Referenced
- Companies Act 1967 (Singapore), s 216A (including s 216A(5))
- Rules of Court 2021 (Singapore), O 3 r 2(2)
- Rules of Court 2021 (Singapore), O 15 r 12(4)
- Companies Act (comparative references)
- Companies Act 1967 (comparative references)
- Companies Ordinance (Cap 622) (Hong Kong), s 737(2)(a) (comparative)
- Australian Corporations Act / Corporations Act 2001 (comparative references)
- HK Companies Ordinance (comparative references)
Cases Cited
- Sinwa SS (HK) Co Ltd v Nordic International Ltd [2016] 4 SLR 320
- Vivaz Group Holdings Pte Ltd v TripleOne (Cambodia) Investment Pte Ltd [2025] SGHC 176 (Vivaz (Merits))
- [2025] SGHC 176
- [2025] SGHC 184
- [2024] SGHC 47
- [2010] SGHC 174
- [2025] SGHC 176
- [2025] SGHC 184
- [2005] SGCA 3
Source Documents
This article analyses [2025] SGHC 202 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.